STELLA PHARMA CORPORATION

4888・Growth Market・Pharmaceuticals

Official website

STELLA PHARMA CORPORATION

4888・Growth Market・Pharmaceuticals

Official website

STELLA PHARMA CORPORATION4888

Reference Indicators

Market Cap

104¥100M

P/E (Forecast)

—

P/B

4.3x

Dividend Yield (Forecast)

0.00%

ROE

-32.2%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	100	229	269	961	323
Gross Profit	84	206	217	845	279
SG&A Expenses	826	1,013	977	935	1,028
Operating Income	-741	-806	-760	-90	-748
Non-operating Income	18	40	4	11	18
Non-operating Expenses	40	9	4	59	47
Ordinary Income	-764	-775	-760	-137	-778
Extraordinary Losses	—	—	0	—	—
Pre-tax Income	-764	-775	-760	-137	-778
Income Taxes	3	2	2	2	2
Net Income	-767	-778	-763	-140	-780
EBITDA	-707	-771	-725	-55	-720
Gross Margin	84.8%	90.3%	80.6%	88.0%	86.3%
Operating Margin	-741.2%	-352.2%	-282.1%	-9.4%	-231.6%
ROA	-16.3%	-18.0%	-20.0%	-2.6%	-17.4%
ROE	-24.9%	-28.4%	-32.2%	-4.4%	-32.2%